We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
18 hedge funds and large institutions have $3.72M invested in Interpace Biosciences, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
57% more capital invested
Capital invested by funds: $2.37M → $3.72M (+$1.36M)
38% more funds holding
Funds holding: 13 → 18 (+5)
Holders
18
Holders Change
+5
Holders Change %
+38.46%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.59M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$660K |
| 3 |
VF
Virtu Financial
New York
|
+$158K |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$110K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$59.2K |
Top Sellers
| 1 |
TSS
Two Sigma Securities
New York
|
-$72K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$725 |
| 3 |
Morgan Stanley
New York
|
-$725 |
